Replies to post #392535 on Amarin Corp Plc (AMRN)

[couldbebetter]

Thanks Raf!

[studythosestocks]

Thx Raf. I’ll take it

[mrmainstreet]

Thanks Raf, don't like to see negative growth but happy that generics fell more. KM needs to continue to stabilize the US market with more exclusive deals or authorized generic. The court case will take years we don't have.

The sooner Denner takes control of the BOD the better IMO. GIA is dead and the company needs to be sold.

[rafunrafun]

Scripts for week ending November 4, 2022

Drug Industry TRx: -0.2% w/w; +7.2% y/y

Vascepa
TRx 62,438; -0.3% (-216) w/w; -21.8% y/y
NRx 28,616; +0.8% (+222) w/w; -19.5% y/y
Ref 33,822; -1.3% (-439) w/w; -23.7% y/y

Fake Vascepa
TRx 40,787; -0.3% (-124) w/w; As % of total V: 39.5%
NRx 19,270; -1.1% (-220) w/w; As % of total V: 40.2%
Ref 21,517; +0.4% (+96) w/w; As % of total V: 38.9%

Fake Vascepa by Manufacturer
Hikma - TRx 14,271; +114 w/w; Generic share 35.0%; Total V share 13.8%
Reddy - TRx 18,684; -330 w/w; Generic share 45.8%; Total V share 18.1%
Apotex - TRx 7,631; +43 w/w; Generic share 18.7%; Total V share 7.4%
Teva - TRx 200; +48 w/w; Generic share 0.5%; Total V share 0.2%

Vascepa + Fake Vascepa
TRx 103,225; -0.3% (-340) w/w; +2.2% y/y
NRx 47,887; +0.0% (+3) w/w; +0.7% y/y
Ref 55,339; -0.6% (-342) w/w; +3.6% y/y

Lovaza (Fake & Brand)
TRx 63,305; +0.2% (+141) w/w; +1.2% y/y
NRx 30,761; +3.1% (+330) w/w; +0.7% y/y
Ref 32,544; -0.6% (-189) w/w; +1.6% y/y